Barclays downgrades Cymer, Inc. (Nasdaq: CYMI) from Overweight to Equalweight. PT lowered from $42 to $30.

Barclays analyst says, "In step ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE